About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
Investors
Contact us
Investors
annual reportS
RAD Annual Report June 2022
September 2022
Download
RAD ESG Report 2022
September 2022
Download
shareholder newsletter
Radiopharm Newsletter December 2022
December 2022
Download
Radiopharm Newsletter July 2022
July 2022
Download
Radiopharm Newsletter March 2022 - Meet our CEO in Australia
March 2022
Download
Radiopharm Theranostics Newsletter Dec 2021
December 2021
Download
ANalyst coverage
Bell Potter Initiation of Coverage - Going After Cancer
March 2023
Download
Diamond Equity Research update Valuation at 70 cents per share
February 2023
Download
Diamond Equity Research update Valuation to 70 cents per share
December 2022
Download
Diamond Equity Research increases Valuation to 88 cents per share
August 2022
Download
Bioshares RAD Update 17 June 2022
June 2022
Download
Bioshares - RAD Update 3 June 2022
June 2022
Download
Diamond Equity Research - Valuation at 87 cents per share - Another meaningful addition to the Pipeline
June 2022
Download
Diamond Equity Research increases valuation to 87 cents per share - Transformative acquisition and progress in clinical trials to drive value
April 2022
Download
Diamond Equity Research Report Feb 2022
February 2022
Download
Diamond Equity Research initiates coverage with valuation 84 cents per share Jan 2022
January 2022
Download
Radiopharm (ASX:RAD) - Independent Investment Research initiates coverage with valuation of 86 cents per share
December 2021
Download
corporate governance
Radiopharm Theranostics Prospectus and Supplementary Disclaimers
Download
Radiopharm Theranostics Prospectus
Download
Radiopharm Theranostics Supplementary Prospectus
Download
Corporate Governance
Download
corporate policies
Privacy Policy
Download
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.